The phenomenon of zonal resistance to lincomycin, which is characteristic of most clinical isolates with lincomycin resistance in Streptococcus pyogenes, has been studied. These strains grow within a defined concentration range of lincomycin (.60 to 200 jig/ml), or at lincomycin concentrations below the miniimal inhibitory concentration for susceptible strains. It is shown that the zonal growth phenomenon is a stable phenotype and results from induction of resistance only within the zonal concentration range of lincomycin. These strains also possess inducible resistance to erythromycin which is nonzonal in character. One-step mutations to constitutive resistance have been isolated which are of two types: constitutive for lincomycin or for erythromycin, but not for both. Those strains with constitutive erythromycin resistance retain their zonal resistance for lincomycin. Mutants doubly constitutive for both lincomycin and erythromycin can be obtained by a second mutational step from either of the singly constitutive mutants. Satellite deoxyribonucleic acid has been shown to be present in the zonal resistant strains. A plasmid, pSM10419, of 14.9 megadaltons, has been isolated from one of the doubly constitutive mutants and used to jointly transform Streptococcus sanguis strain Challis to constitutive resistance to both lincomycin and erythromycin. From this, a multicopy plasmid of reduced size, pSM10 (5.4 megadaltons), which retains its resistance phenotype, has been isolated and mapped with restriction endonucleases HindIII (three sites), EcoRI (one site), KpnI (one site), and HpaI (one site). The staphylococcal plasmid pC221 (2.9 megadaltons; chloramphenicol resistant) has been fused to pSM10 at the EcoRI site resulting in a chixneric plasmid, pSM10221 (8.3 megadaltons), which retains resistance to chloramphenicol, erythromycin, and lincomycin. pSM10 is therefore suggestive as an effective cloning vehicle for the genus Streptococcus.
Streptococcal strains of clinical origin which are resistant to lincomycin (Lmr) can be divided into two phenotypic groups according to their growth behavior (13, 14) . In one group, the MLS resistance phenotype group (resistance to macrolides, lincosaminides, and streptogramin B group antibiotics), growth on all of these antibiotics is uniform up to their respective minimal inhibitory concentrations (MICs). In the second group, the zonal resistance phenotype group, which represents the majority of the clinical Lmr isolates of Streptococcus pyogenes (14) , the growth behavior in the presence of lincomycin differs. These strains grow within a sharply defined zonal range of lincomycin concentrations (-60 to 200 ,ug/ml), with no growth above or below this range; they can, of course, grow at lincomycin concentrations below the MIC for susceptible strains. Their growth response to erythromycin is the same as that of the MLS resistance phenotype (21) .
Plasmid deoxyribonucleic acid (DNA) is associated with the MLS resistance phenotype (4, 8-10, 16, 20, 22) , and the biochemical basis for resistance is known to result from methylation of specific adenine residues in 23S ribosomal ribonucleic acid (RNA) (31 For transforming strain Challis with native or enzymatically treated plasmid DNA, 1-ml samples of the competent culture were exposed to 20-to 250-pl volumes of 10 mM Tris-hydrochloride, pH 7.5, containing 1 to 2 ,ug of DNA. The transformation mixtures were incubated for 150 min at 37°C and then plated on SA for making viable counts and on the same medium containing 10,ug of erythromycin or chloramphenicol, or both, for selecting transformants. After incubation for 48 h at 37°C, transformant colonies to be studied further were isolated and purified by two repeated single-colony isolations.
Enzymatic treatment ofplasmid DNA and agarose gel electrophoresis. Restriction endonucleases and T4 polynucleotide ligase were prepared in Jena, GDR, according to established procedures (15, 25) . Plasmid DNA samples (0.5 to 1 ,ug) contained in 10 to 50 LI of the appropriate buffers (15) were exposed to 2 to 5 U of a restriction endonuclease and incubated at 37°C for 1 to 3 h, depending on the enzyme employed. When digestions by two endonucleases were performed, the enzyme requiring the higher salt concentration was used last. The reactions were terminated by the addition of 0.1 volume of a stop solution containing 20% (vol/vol) glycerol, 200 mM EDTA, and 0.01% bromophenol blue. Plasmid DNA fragments were resolved on 1 or 1.2% agarose (Sigma) vertical slab gels (180 by 145 by 2.5 mm) (27) by electrophoresing for 12 to 16 h at 30 V. The gels were stained in aqueous ethidium bromide solution (1 Mg/ml), destained in water, and visualized under short-wavelength ultraviolet light. Size estimates of the plasmid fragments were based on the migration rate relative to endonuclease-generated fragments of X (24), pBR322, and pBR325 DNAs (7, 28) , assuming a logarithmic relationship between molecular mass and electrophoretic mobility and an average mass of 641 daltons for a nucleotide pair.
For ligation of EcoRI-cleaved plasmid DNAs, the endonuclease reactions were stopped by heating at 65°C for 5 min, and equimolar mixtures of the appropriate cleaved DNAs were treated with DNA ligase as described (5 (Fig. 2G to I ) was selected by plating 10416 on SA containing an inhibitory concentration of erythromycin (10 ,ug/ml). This strain did not require induction by erythromycin to express high-level erythromycin resistance (MIC = 1 mg/ml), but remained zonally resistant to lincomycin in the uninduced state. Again, the zonal growth in lincomycin could be eliminated by prior erythromycin induction. Finally, strain SM10419 (Fig. 2J to L) was selected as a second-step mutant by plating SM10417 on SA containing 100 ,ug of erythromycin per ml. SM10419 expressed constitutive resistance to both erythromycin and lincomycin, with the MICs of the two antibiotics being about 500 ,ug/ ml. This mutant analysis provided conclusive evidence that resistance to lincomycin and erythromycin in zonal resistance strain 10416 is of the inducible type and that constitutive resistance is expressed only to the antibiotic used for selection. Generalized constitutive resistance to both intermediate concentrations of lincomycin and high concentrations of erythromycin required two mutational events in a stepwise manner. In general, the resistance levels expressed in the constitutive state were somewhat higher than the corresponding levels attained by erythromycin induction (Fig. 2) , indicating that the inducing ability of the drug was less than complete. Although studied in less detail, investigation of the other zonal resistance strains included in this work (Table 1) confirmed the basic characteristics of the zone phenomenon established for strain 10416. A special feature of SM6518 was that acquisition of constitutive erythromycin resistance (MIC = 1 mg/ml) was accompanied by increased sensitivity to zonal lincomycin concentrations in the uninduced state (Fig. 3) , so that in liquid medium, 48 h of incubation was necessary for the zone phenomenon to appear. Erythromycin induction, however, led to the samre level of lincomycin resistance as shown by the induced wild type (MIC = 500 ,ug/ml). Awareness of the possible existence of such strains may be helpful in assessing antibiotic susceptibility patterns in the clinical microbiology laboratory.
Plasmid DNA related to zonal resistance. All of the zonal resistance strains and their constitutive mutants listed in Table 1 mation of a satellite DNA peak (-2% of total DNA) after ethidium bromide-CsCl density-gradient centrifugation of their total DNA. One troublesome aspect of these experiments was our inability to demonstrate the presence of CCC plasmid molecules after sedimenting the satellite DNA through neutral and alkaline sucrose gradients. This suggests that supercoiled DNA present in the zonal resistance strains could not be stably maintained in this form subsequent to dye-CsCl density-gradient centrifugation. Instability of CCC DNA extracted from streptococci has also been observed by others (18) To identify a stable plasmid DNA species related to drug resistance, strain Challis was therefore used as the recipient for transformation to erythromycin resistance with unfractionated DNA from SM10419. When selection was made with 0.5 ug of erythromycin per ml, 4 x 107 CFU of a competent culture exposed to 58 jig of SM10419 DNA yielded 15 (Fig. 4) . Of these, HindIII-BB', -EE', and -FF' were pairs of identical fragments resulting from long, nontandem inverted repeats as detected by electron microscopy of self-annealed molecules after denaturation and renaturation of plasmid DNA (6) . EcoRI digestion of pSM10419 generated two fragments ( judged by HindIII analysis. The other transformant harbored a plasmid, designated pSM10, with a mass of 5.4 Md as determined by agarose gel electrophoresis of native and endonucleasecleaved DNA (Table 2) . Of the three HindIII cleavage fragments of pSM10, HindIII-B and HindIII-C corresponded, respectively, to single complements of HindIII-BB' and HindIII-EE' of pSM10419, whereas the new HindIII-A fragment must represent the fusion product of nondeleted stretches of DNA flanking the HindIII-B-E/B'-E' segment of the parental plasmid. Single or double digestion of pSM10 with additional restriction endonucleases yielded the data listed in Table 2 , which were used to construct the cleavage site map (see Fig. 6 below) .
Construction of a hybrid plasmid between pSM10 and pC221. pC221 has single sites for EcoRI and HindIII (0.14 Md apart), into both of which DNA can be cloned without disrupting either plasmid replication or chloramphenicol resistance (33) . Native pC221 DNA tranformed competent strain Challis cultures (4 x 107 CFU/ml) to chloramphenicol resistance at a frequency of 458 transformants per 1 ,ug of DNA, showing that the chloramphenicol acetyltransferase gene of the staphylococcal plasmid can be expressed in S. sanguis. To test whether or not DNA insertion into the EcoRI site of pSM10 inactivates expression of erythromycin resistance, pC221 DNA (1 jig) and pSM10 DNA (1 jig) were digested with EcoRI, mixed, and treated with DNA ligase. The ligation mixture was used to transform strain Challis. By using selection for erythromycin resistance alone, 4 x 107 CFU of a competent culture exposed to 2 ,ug of ligated DNA yielded about 1.2 x 104 Emr colonies, 96 of which were simultanesoly Cmr, as tested by replica plating. Selection for erythromycin plus chloramphenicol resistance under otherwise identical conditions yielded two doubly resistant colonies. No colonies were obtained if either the cells or the DNA was omitted. Plasmid DNA was extracted from one doubly resistant clone that appeared on a plate containing erythromycin and subjected to electron microscopy and genetic and restriction endonuclease analyses.
Contour length measurements showed that this clone carried a single plasmid, referred to as pSM10221, whose size was the sum of the sizes of the parental plasmids, namely, 4.25 ± 0.18 ,um, corresponding to 8.3 Md (12 molecules measured). EcoRI cleaved pSM10221 into two fragments (5.4 and 2.9 Md) having sizes that matched those of the EcoRI-cleaved parental DNAs (Fig. 5) pSM10221 DNA, when used in a second round of transformation, could transform the Challis strain to both erythromycin and chloramphenicol resistance, with the two markers transferring at the same efficiency and exhibiting complete linkage. Thus, more than 1,000 transformants selected for erythromycin resistance were also Cmr and, similarly, all Cmr transformants tested (1,620) were also Emr. Furthermore, the observed genotypes of the strains carrying the parental or recombinant plasmids were confirmed by the MIC values to erythromycin and chloramphenicol, which showed that the hybrid plasmid conferred resistance levels to the two drugs identical to those determined by the respective constituent plasmids (Table 3) . DISCUSSION The induction and mutation studies establish that zonal resistance to lincomycin is inducible. The simplest explanation for the zone phenomenon therefore is that lincomycin concentrations of 60 to 200 ,ug/ml induce resistance, whereas in lower concentrations, resistance remains repressed. The growth in very low lincomycin concentrations (<0.1 ,ig/ml) is due to intrinsic resistance to the antibiotic and therefore has nothing to do with the particular phenotype. In contrast to lincomycin, erythromycin can act as an inducer of resistance only at low, subinhibitory concentrations, whereas it inhibits protein synthesis at higher concentrations and is therefore unable to induce cells in situ. The (23) . Unfortunately, corresponding data are not available for zonal resistance strains, so that at the present state of knowledge, it seems premature to propose a model concerning the mechanism of regulation of resistance. The genetic and physical data presented in this paper provide evidence that zonal resistance to lincomycin is related to plasmid pSM10419. The difficulties encountered in extracting CCC DNA from the original strains seem to be related to some peculiarities of the specific plasmid pool in zonal resistance strains because the pELl plasmid (22) 
